Bone Marrow Transplant Team Completes 1st Allogenic Transplant
The UC Health George L. Strike Bone Marrow Transplant Center located in the Hoxworth Building on UCs campus completed its first allogeneic stem cell transplant on Wednesday, Dec. 11.
"Our team is very excited to have reached this milestone, says Elias Anaissie, MD, director of the Hematologic Malignancy and Bone Marrow Transplant Program and John & Gladys Strauss Endowed Chair in Cancer Research at UC. "It represents another step on our way to becoming patients preferred choice for all types of hematologic malignancy care.
Allogeneic stem cell transplantation involves the receipt of bone marrow or blood stem cells from a tissue-matched (HLA-matched) donor who is often a relative of the patient. Allogeneic stem cell transplantation is an inpatient procedure requiring a post-transplant hospital stay while blood cell counts recover.
In the past month, the center also achieved its first outpatient autologous bone marrow transplant and was awarded accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accredits hospitals and medical institutions that meet the most rigorous standards when offering therapies that use adult stem cells for patients with blood cancers and diseases.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.